The impact of Obamacare on the U.S. economy and its health-care system remains a matter of intense debate. More Americans have health insurance, but the longterm effects on the cost of medical care and on government spending are still unknown.
For health-care companies, though, one thing is clear: Instead of being the economic catastrophe predicted by congressional Republicans, all of whom voted against it, Obamacare, at worst, is benign for U.S. business and, at best, is making global investors rich.
Read Full Article »